The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups - Prescott,R.; Nakai,H.; Saenko,E.L. (Blood, 1997)